Literature DB >> 4019879

Characteristics of the psychoses of late onset in children and adolescents (a comparative study of hallucinating children).

M E Garralda.   

Abstract

In a retrospective design, 20 children and adolescents with psychoses of late onset and hallucinations were compared with 20 children with conduct or emotional disorders who also had hallucinations. Marked differences emerged between the two groups. Psychotic subjects showed significantly more delusions, abnormalities in language production, inappropriate affect, bizarre behaviour, hypoactivity, and social withdrawal. Some subjects had symptoms which indicated a specially profound breakdown in personality functioning, but schneiderian and other schizophrenic symptoms were relatively rare. This questions their diagnostic value in the psychoses of late onset of children and adolescents.

Entities:  

Mesh:

Year:  1985        PMID: 4019879     DOI: 10.1016/s0140-1971(85)80047-6

Source DB:  PubMed          Journal:  J Adolesc        ISSN: 0140-1971


  6 in total

1.  Adolescent psychoses: treatment and service provision.

Authors:  W L Parry-Jones
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

2.  Early onset psychotic disorders: diagnostic stability and clinical characteristics.

Authors:  J McClellan; C McCurry
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

3.  Comparison of psychotic and autistic children using behavioral observation.

Authors:  M Matese; J L Matson; J Sevin
Journal:  J Autism Dev Disord       Date:  1994-02

4.  A follow-up study of early onset psychosis: comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders.

Authors:  J M McClellan; J S Werry; M Ham
Journal:  J Autism Dev Disord       Date:  1993-06

Review 5.  Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).

Authors:  Edith M Jolin; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

6.  Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease.

Authors:  Mohd Nasir Mat Nor; Ilva D Rupenthal; Colin R Green; Monica L Acosta
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.